Safety Issues
7
Pipeline Programs
7
Companies
7
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
7
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
7 companies ranked by most advanced pipeline stage
Bavarian NordicDenmark - Kvistgard
1 program1
MVA-BN-Brachyury/ FPV-BrachyuryPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Cinclus PharmaLinaprazan glurate
Vicore PharmaC106 solution
CerevanceCVN766
Q32 BioADX-914
Bavarian NordicMVA-BN-Brachyury/ FPV-Brachyury
Gossamer BioGB002
Nxera PharmaHTL0018318
Clinical Trials (7)
Total enrollment: 234 patients across 7 trials
Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam
Start: Nov 2022Est. completion: May 202335 patients
Phase 1Completed
First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects
Start: Jun 2022Est. completion: Jun 202380 patients
Phase 1Completed
Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers
Start: Jan 2022Est. completion: Nov 2022
Phase 1Completed
Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers
Start: Sep 2020Est. completion: Jan 202242 patients
Phase 1Completed
Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury)
Start: Jan 2018Est. completion: Jun 202011 patients
Phase 1Completed
Phase 1A Safety Trial of Inhaled PK10571 (GB002)
Start: Sep 2017Est. completion: Dec 201866 patients
Phase 1Completed
Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects
Start: May 2017Est. completion: Aug 2017
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
7 companies competing in this space